Practice Committee of the American Society for Reproductive M. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114:6.

Google Scholar 

Chang Y, Li J, Li X, Liu H, Liang X. Egg quality and pregnancy outcome in young infertile women with diminished ovarian reserve. Med Sci Monit. 2018;24:7279–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Devine K, Mumford SL, Wu M, DeCherney AH, Hill MJ, Propst A. Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril. 2015;104:3.

Article  Google Scholar 

Jaswa EG, McCulloch CE, Simbulan R, Cedars MI, Rosen MP. Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity. Fertil Steril. 2021;115:4.

Article  Google Scholar 

Li XL, Wang L, Lv F, Huang XM, Wang LP, Pan Y, et al. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96:12.

Google Scholar 

Nagels HE, Rishworth JR, Siristatidis CS, Kroon B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2015;(11):CD009749. https://doi.org/10.1002/14651858.CD009749.pub2.

Li J, Yuan H, Chen Y, Wu H, Wu H, Li L. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection. Int J Gynaecol Obstet. 2015;131:3.

Article  Google Scholar 

Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Hum Reprod. 1999;14:7.

Article  Google Scholar 

Giannubilo SR, Orlando P, Silvestri S, Cirilli I, Marcheggiani F, Ciavattini A, et al. CoQ10 supplementation in patients undergoing IVF-ET: the relationship with follicular fluid content and oocyte maturity. Antioxidants (Basel). 2018;7:10.

Google Scholar 

Donato J Jr, Wasinski F, Furigo IC, Metzger M, Frazao R. Central regulation of metabolism by growth hormone. Cells. 2021;10:1.

Article  Google Scholar 

Abir R, Garor R, Felz C, Nitke S, Krissi H, Fisch B. Growth hormone and its receptor in human ovaries from fetuses and adults. Fertil Steril. 2008;90(4 Suppl):1333–9.

Article  CAS  PubMed  Google Scholar 

Owen EJ, West C, Mason BA, Jacobs HS. Co-treatment with growth hormone of sub-optimal responders in IVF-ET. Hum Reprod. 1991;6:4.

Article  Google Scholar 

Cai MH, Gao LZ, Liang XY, Fang C, Wu YQ, Yang X. The effect of growth hormone on the clinical outcomes of poor ovarian reserve patients undergoing in vitro fertilization/intracytoplasmic sperm injection treatment: a retrospective study based on POSEIDON criteria. Front Endocrinol (Lausanne). 2019;10:775.

Article  PubMed  Google Scholar 

Gong Y, Zhang K, Xiong D, Wei J, Tan H, Qin S. Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial. Reprod Biol Endocrinol. 2020;18:1.

Article  Google Scholar 

Dogan S, Cicek OSY, Demir M, Yalcinkaya L, Sertel E. The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response. J Gynecol Obstet Hum Reprod. 2021;50:2.

Article  Google Scholar 

Liu FT, Hu KL, Li R. Effects of growth hormone supplementation on poor ovarian responders in assisted reproductive technology: a systematic review and meta-analysis. Reprod Sci. 2021;28:4.

Google Scholar 

Zhang Y, Zhang C, Shu J, Guo J, Chang HM, Leung PCK, et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update. 2020;26:2.

Article  Google Scholar 

Weall BM, Al-Samerria S, Conceicao J, Yovich JL, Almahbobi G. A direct action for GH in improvement of oocyte quality in poor-responder patients. Reproduction. 2015;149:2.

Article  Google Scholar 

Regan SLP, Knight PG, Yovich JL, Arfuso F, Dharmarajan A. Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes. Fertil Steril. 2018;110:7.

Article  Google Scholar 

Dosouto C, Calaf J, Polo A, Haahr T, Humaidan P. Growth hormone and reproduction: lessons learned from animal models and clinical trials. Front Endocrinol (Lausanne). 2019;10:404.

Article  PubMed  PubMed Central  Google Scholar 

Xu YM, Hao GM, Gao BL. Application of growth hormone in in vitro fertilization. Front Endocrinol (Lausanne). 2019;10:502.

Article  PubMed  PubMed Central  Google Scholar 

Fuentes A, Sequeira K, Tapia-Pizarro A, Munoz A, Salinas A, Cespedes P, et al. Androgens profile in blood serum and follicular fluid of women with poor ovarian response during controlled ovarian stimulation reveals differences amongst POSEIDON stratification groups: a pilot study. Front Endocrinol (Lausanne). 2019;10:458.

Article  PubMed  PubMed Central  Google Scholar 

Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol. 2009;7:40.

Article  PubMed  PubMed Central  Google Scholar 

Wallace M, Cottell E, Gibney MJ, McAuliffe FM, Wingfield M, Brennan L. An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental potential, and implantation outcome. Fertil Steril. 2012;97:5.

Article  Google Scholar 

Shehadeh A, Bruck-Haimson R, Saidemberg D, Zacharia A, Herzberg S, Ben-Meir A, et al. A shift in follicular fluid from triacylglycerols to membrane lipids is associated with positive pregnancy outcome. FASEB J. 2019;33:9.

Article  Google Scholar 

Nagy RA, Homminga I, Jia C, Liu F, Anderson JLC, Hoek A, et al. Trimethylamine-N-oxide is present in human follicular fluid and is a negative predictor of embryo quality. Hum Reprod. 2020;35:1.

Article  Google Scholar 

de la Barca JMC, Boueilh T, Simard G, Boucret L, Ferré-L'Hotellier V, Tessier L, et al. Targeted metabolomics reveals reduced levels of polyunsaturated choline plasmalogens and a smaller dimethylarginine/arginine ratio in the follicular fluid of patients with a diminished ovarian reserve. Hum Reprod. 2017;32:11.

Google Scholar 

Liang C, Zhang X, Qi C, Hu H, Zhang Q, Zhu X, et al. UHPLC-MS-MS analysis of oxylipins metabolomics components of follicular fluid in infertile individuals with diminished ovarian reserve. Reprod Biol Endocrinol. 2021;19:1.

Article  Google Scholar 

Busnelli A, Somigliana E, Cirillo F, Levi-Setti PE. Is diminished ovarian reserve a risk factor for miscarriage? Results of a systematic review and meta-analysis. Hum Reprod Update. 2021;27:6.

Article  Google Scholar 

Cohen J, Chabbert-Buffet N, Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder--a plea for universal definitions. J Assist Reprod Genet. 2015;32:12.

Article  Google Scholar 

Smart KF, Aggio RBM, Van Houtte JR, Villas-Bôas SG. Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography-mass spectrometry. Nat Protoc. 2010;5:10.

Article  Google Scholar 

Han TL, Cannon RD, Gallo SM, Villas-Boas SG. A metabolomic study of the effect of Candida albicans glutamate dehydrogenase deletion on growth and morphogenesis. NPJ Biofilms Microbiomes. 2019;5(1):13.

Article  PubMed  PubMed Central  Google Scholar 

Guo G, McKenzie EJ, Jones B, Zarate E, Seymour J, Baker PN, et al. MassOmics: an R package of a cross-platform data processing pipeline for large-scale GC-MS untargeted metabolomics datasets. Zendo. 2021. https://doi.org/10.5281/zenodo.4961895.

Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.

Article  PubMed  PubMed Central  Google Scholar 

Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer; 2009.

Book  Google Scholar 

Liu H, Feng Y, Xu M, Yang J, Wang Z, Di G. Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide. Cell Commun Signal. 2018;16:1.

Article  Google Scholar 

Cordes T, Lucas A, Divakaruni AS, Murphy AN, Cabrales P, Metallo CM. Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury. Mol Metab. 2020;32:122–35.

Article  CAS  PubMed  Google Scholar 

Wang S, Zheng Y, Li J, Yu Y, Zhang W, Song M, et al. Single-cell transcriptomic atlas of primate ovarian aging. Cell. 2020;180:3.

Article  Google Scholar 

Park SU, Walsh L, Berkowitz KM. Mechanisms of ovarian aging. Reproduction. 2021;162:2.

Article  Google Scholar 

Li XH, Wang HP, Tan J, Wu YD, Yang M, Mao CZ, et al. Loss of pigment epithelium-derived factor leads to ovarian oxidative damage accompanied by diminished ovarian reserve in mice. Life Sci. 2019;216:129–39.

Article  CAS  PubMed  Google Scholar 

Uppangala S, Fernandes G, Salian SR, Kumar P, Talevi R, Kalthur G, et al. Reduced ovarian response to controlled ovarian stimulation is associated with increased oxidative stress in the follicular environment. Reprod Biol. 2020;20:3.

Article  Google Scholar 

Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16:1.

Article  Google Scholar 

Jahromi BN, Sadeghi S, Alipour S, Parsanezhad ME, Alamdarloo SM. Effect of melatonin on the outcome of assisted reproductive technique cycles in women with diminished ovarian reserve: a double-blinded randomized clinical trial. Iran J Med Sci. 2017;42:1.

Google Scholar 

Yigiter M, Halici Z, Odabasoglu F, Keles ON, Atalay F, Unal B, et al. Growth hormone reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Eur J Obstet Gynecol Reprod Biol. 2011;157:1.

Article  Google Scholar 

Luberda Z. The role of glutathione in mammalian gametes. Reprod Biol. 2005;5:1.

Google Scholar 

Li HJ, Sutton-McDowall ML, Wang X, Sugimura S, Thompson JG, Gilchrist RB. Extending prematuration with cAMP modulators enhances the cumulus contribution to oocyte antioxidant defence and oocyte quality via gap junctions. Hum Reprod. 2016;31:4.

Article  Google Scholar 

He J, Yao G, He Q, Zhang T, Fan H, Bai Y, et al. Theaflavin 3, 3′-digallate delays ovarian aging by improving oocyte quality and regulating granulosa cell function. Oxidative Med Cell Longev. 2021;2021:7064179.

Article